Indications
Therapeutic Asset Ratings
13,145 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
tpm502
Celiac Disease
Topas Therapeutics GmbH
P2
B
(57)
tq05105 tablets
Myelofibrosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P2
B
(57)
Trastuzumab
Rectum Adenocarcinoma
Academic and Community Cancer Research United
P2
B
(57)
Trastuzumab
Chemotherapy-Induced Toxicity
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
P2
B
(57)
Trastuzumab
Colorectal Adenocarcinoma
Academic and Community Cancer Research United
P2
B
(57)
Trastuzumab
Progesterone-Receptor Negative Breast Cancer
Jules Bordet Institute
P2
B
(57)
Trastuzumab
Progesterone-Receptor Positive Breast Cancer
Massachusetts General Hospital
P2
B
(57)
Trastuzumab Deruxtecan
Neoplastic Meningitis
Memorial Sloan Kettering Cancer Center
P2
B
(57)
Trastuzumab Emtansine
Metastatic Neoplasm
Genentech, Inc.
P2
B
(57)
Trastuzumab Emtansine
Urinary Bladder Carcinoma
Hoffmann-La Roche
P2
B
(57)
Trastuzumab Imbotolimod
HER2 Positive Breast Carcinoma
Bolt Biotherapeutics, Inc.
P2
B
(57)
Treosulfan
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer Center
P2
B
(57)
Treosulfan
Congenital Amegakaryocytic Thrombocytopenia
Fred Hutchinson Cancer Center
P2
B
(57)
Treosulfan
Diamond-Blackfan Anemia
Fred Hutchinson Cancer Center
P2
B
(57)
Treosulfan
GATA2 Deficiency With Susceptibility To MDS/AML
Fred Hutchinson Cancer Center
P2
B
(57)
Treosulfan
SAMD9L-Related Spectrum And Myeloid Neoplasm Risk
Fred Hutchinson Cancer Center
P2
B
(57)
Treosulfan
SAMD9-Related Spectrum And Myeloid Neoplasm Risk
Fred Hutchinson Cancer Center
P2
B
(57)
Treosulfan
Inherited Sideroblastic Anemia
Fred Hutchinson Cancer Center
P2
B
(57)
Treosulfan
Paroxysmal Nocturnal Hemoglobinuria
Fred Hutchinson Cancer Center
P2
B
(57)
Treosulfan
Shwachman-Diamond Syndrome
Fred Hutchinson Cancer Center
P2
B
(57)
Trimetazidine
Metabolic Dysfunction-Associated Steatotic Liver Disease
October 6 University
P2
B
(57)
Tucatinib
Colorectal Adenocarcinoma
Academic and Community Cancer Research United
P2
B
(57)
Tucidinostat
Acute Myeloid Leukemia
Dongguan People's Hospital
P2
B
(57)
Tucidinostat
Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P2
B
(57)
Tucidinostat
T Lymphoblastic Leukemia/Lymphoma
Zhejiang University
P2
B
(57)
Showing 3551 to 3575 of 13,145 assets
Previous
Page 143 of 526
Next